
HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand
Author(s) -
Catherine McLean,
Janneke van de Wijgert,
Heidi E. Jones,
John M. Karon,
Janet M. Mcnicoll,
Sara Whitehead,
Sarah Braunstein,
Jullapong Achalapong,
Supaporn Chaikummao,
Jordan W. Tappero,
Lauri E. Markowitz,
Peter H. Kilmarx
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328333bf89
Subject(s) - viral load , medicine , placebo , viral shedding , immunology , randomization , crossover study , sex organ , vaginal flora , lentivirus , randomized controlled trial , human immunodeficiency virus (hiv) , young adult , viral disease , vagina , surgery , biology , virus , pathology , alternative medicine , genetics
To evaluate the safety, including impact on genital HIV RNA shedding, of Carraguard vaginal gel in HIV-infected women.